Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 543.60M | £ 445.80M | £ 773.60M | £ 240.10M | £ 185.00M |
Total Assets | £ 2.82B | £ 2.52B | £ 3.18B | £ 2.71B | £ 2.92B |
Total Debt | £ 1.69B | £ 1.60B | £ 2.25B | £ 2.27B | £ 2.23B |
Net Debt | £ 1.15B | £ 1.15B | £ 1.48B | £ 2.03B | £ 2.04B |
Total Liabilities | £ 2.51B | £ 2.24B | £ 2.87B | £ 2.77B | £ 2.72B |
Stockholders Equity | £ 225.00M | £ 211.90M | £ 240.30M | £ -116.00M | £ 130.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |